what are glp 1 receptor agonist medicines GLP-1 agonists promising but unproven treatments for alcohol and substance use disorders How GLP-1 medications are transforming

Studies have shown reductions in Hb A 1c and weight loss in this population

Cases of weight-loss drug poisoning In 2021, the New Jersey Poison Control Center recorded 29 GLP-1 exposure cases

Mechanistic and precision medicine studies In addition to clinical outcomes, mechanistic studies using biomarkers, vascular imaging, and renal function assessments may improve our understanding of how GLP-1 RAs lower BP

AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease

When one drug inhibits CYP enzymes responsible for metabolising another CNS drug, plasma and brain concentrations may rise, increasing the risk of toxicity